Chair
Executive Committee
Vice Chair
Chris Garabedian
Chairman & CEO, Xontogeny
Treasurer
Michael O’Hara
Partner, Deloitte
Counsel
Larry Wittenberg
Partner, Goodwin
Clerk
Tamar Thompson
Head, Corporate Affairs, Alexion/AstraZeneca Rare Disease
Immediate Past Chair
Charles Wilson
Immediate Past Chair, MassBio
Directors
Cheryl Blanchard
President & CEO, Anika Therapeutics, Inc.
Melissa Bradford-Klug
President & Chief Business Officer, RareStone Inc.
Tim P. Clackson
President & CEO, Theseus Pharmaceuticals
Chip Clark
President & CEO, Genocea Biosciencs, Inc.
Sharon Cload
Vice President, Discovery Biotherapeutics, East Coast, Bristol Myers Squibb
Robert Coughlin
Managing Director, Life Sciences, JLL
John Dunlop
Head of Research & Development, Neumora
Eileen A. Elliott
Executive Director, Scientific Affairs & External Partnership and Kendall Square Site Lead, Pfizer
Jeff Elton
CEO, Concerto AI
Alan Eisenberg
Vice President, Global Public Policy & Government Relations, Alnylam Pharmaceuticals
Barbara S. Fox
CEO, Rheos Medicines
Gary Gillheeney
President & CEO, Organogenesis Inc.
Robert Gottlieb
Principal, RMG Associates
Luba Greenwood
Managing Partner, Dana-Farber Cancer Institute, Binney Street Capital; CEO
Jose-Carlos Gutierrez-Ramos
Chief Science Officer, Danaher Corporation
Sue Hager
Chief Marketing Officer, Andreessen Horowitz (a16z) Bio+Health
Martin Heidecker
Chief Investment Officer, AMR Action Fund
Ed Kaye
CEO, Stoke Therapeutics
Chris Leibman
SVP, Value and Access, Biogen
Lizabeth Leveille
Vice President and Head, BD&L Boston & European Innovation Hubs, Merck & Co., Inc.
Liz Lewis
Head of Global Oncology Patient Value, Policy and Access, Takeda
Alice Lin Pomponio
Managing Director, American Cancer Society’s BrightEdge Fund
David Lucchino
Co-founder, President & CEO, Frequency Therapeutics
David Meeker
Chair, President & CEO, Rhythm Pharmaceuticals
Gilmore O’Neill
President & CEO, Editas Medicine
William P. McDermott
Partner, McDermott, Quilty & Miller LLP
Cindy Perettie
Head, Roche Molecular Labs
Adelene Perkins
Chair & CEO, Infinity Pharmaceuticals
Michal Preminger
Head, Johnson & Johnson Innovation, East North America
Chandra Ramanathan
Global Head, Innovation Hubs, Danaher
Eric Rasmussen
Vice President, Government Relations & Public Affairs, Sunovion
Chris Round
President, EMD Serono
Amit K. Sachdev
Executive VP, CPO, COS, Vertex
Bill Sibold
Executive Vice President & Head, Sanofi Genzyme
Kumar Srinivasan
Executive Vice President & CBO, Turning Point Therapeutics
